The MMPI-2 neurotic triad subscales and depression levels after pharmacological treatment in patients with depressive disorders - clinical study.

摘要: SUMMARY Background: Affective disorders provide for one third of the main causes psychiatric inpatient care, both in male and female subjects. An early diagnosis disease with precise identification character its particular symptoms are key important factors efficacy treatment. The goal study was an possible associations between scores neurotic triad MMPI-2 test (hypochondria - Hs, depression D, hysteria Hy), evaluated at initial hospitalization period remission degree assessed by Hamilton Depression Rating Scale (HDRS), following eight weeks treatment SSRI. Subjects methods: A group 50 subjects took part study. HDRS were used performed therapy onset reapplied after 8 continuation. applied beginning Results: Higher Hs (p=0.007), D (p=0.021) Hy scales (p=0.001) associated higher depression, measured onset. highest performance scale (p=0.003) on admission, level pharmacological Conclusion: hypochondria symptoms, patients depressive disorders, severity is being found SSRI agents, scale.